Figure 1From: Evolution in functionality of a metastatic pancreatic neuroendocrine tumour (pNET) causing Cushing’s syndrome: treatment response with chemotherapy (upper figure) 111 Indium-labeled Octreotide scan. Figure 1 (lower figure) Ki-67 immunostaining of liver metastasis (at recurrence) showing a high proliferative rate of 20%.Back to article page